PAD Profile : Erdosteine - Reduction of sputum viscosity

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Erdosteine - Reduction of sputum viscosity

Keywords :

mucolytics, excessive mucous production

Brand Names Include :

Erdotin

Traffic Light Status

Status :

Non Formulary

Important

Formulations :

Important Information :

Not licensed for this indication - refer to guidelines for alternatives

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

NFD1

Comments :

No comments returned.

Documents :

The following guidelines are available for this indication.

No indications returned.

No additional documents returned.

Date

Committee Name

Narrative

06 November 2024

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

03. Respiratory System

03.07.00. Mucolytics